MCK Trading Analysis - 10/09/2026 01:18 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for McKesson (MCK) suggests the following themes that may frame the data below:

• McKesson continued to benefit from elevated pharmaceutical distribution volumes and specialty drug growth through its oncology and biopharma segments.
• Healthcare supply-chain stabilization and GLP-1 drug handling remain a catalyst for distribution margins and volume.
• No major negative regulatory action was broadly reported, though drug-pricing policy headlines remain a sector overhang.
• Low beta (0.17 per fundamentals) indicates MCK has historically been less reactive to broad market swings than peers.
• Context: The embedded technical and options data show strength and bullish flow, consistent with a steady fundamental backdrop rather than a sharp headline shock.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E: 24.80; Trailing EPS: 37.53; Market Cap: 109,256,489,000.00; Shares Outstanding: 116,590,000.00.
• Dividend Yield: 0.40%; Dividend Rate: 3.76; Ex-Dividend Date: 2026-09-01.
• Beta: 0.17 (very low market sensitivity); 52-Week High: 999.00; 52-Week Low: 723.68.
• Institutional Ownership: 58.31%; Average Volume: 851,000.00; Historical Volatility: 26.17%.
• Fiscal Year End: 2026-03-01.
• Missing data: forwardPE, forwardEps, pegRatio, priceToBook, totalRevenue, revenueGrowth, returnOnEquity, profitMargins, debtToEquity, freeCashflow, recommendationKey, targetMeanPrice, numberOfAnalystOpinions are all null.

Revenue growth, margin detail, ROE, and D/E cannot be assessed from the data. Valuation via trailing P/E of 24.80 is the only comparative metric available; no PEG or peer comparison values are present. Fundamentals show a large-cap, low-beta, modest-yield profile with institutional sponsorship near 58%. This aligns with the technical uptrend and bullish options flow but offers no earnings-momentum confirmation due to null fields.

Current Market Position

From the embedded data, the daily close on 2026-10-08 was 934.61. The minute bars show 2026-10-08 opened at 906.65 and traded up to 938.51 intraday, closing 934.61. On 2026-10-09 at 12:50:00, the last minute bar shows open 935.99, high 936.46, low 935.99, close 936.46, with tight range vs prior session.

Recent price action: 30-day range high 938.51, low 847.28. Price is near the top of the 30-day range. Last 5 minute bars on 10-09 show consolidation between 935.83 and 936.82 with lower volume (1,845 to 3,730) vs the 10-08 spike (up to 12,449). Intraday momentum is flat-to-slightly-positive after a strong 10-08 rally.

Technical Analysis

Price (934.61) is above SMA 5 (917.41), SMA 20 (889.55), and SMA 50 (882.44) — full bullish alignment with no bearish crossovers. RSI 67.44 shows strong momentum but not yet overbought (>70). MACD (9.83) > signal (7.86), histogram positive (1.97) = bullish momentum. Bollinger upper is 933.70; price is just above it, indicating expansion / strong trend. 30-day high 938.51 is immediate ceiling; low 847.28 is distant support. ATR 24.21 implies daily movement capacity of ~24 points.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Dollar Volume: 126,540.00 (67.9%) Put Dollar Volume: 59,700.00 (32.1%) Total: 186,240.00

Sentiment: Bullish. Call contracts 20 vs put 15; call trades 4, put trades 4. Pure directional conviction skews call-heavy (67.9% of dollar vol). This aligns with technical strength and confirms near-term upside expectations. No divergence vs price; both price and flow are bullish.

Key Price Levels (Observational Only)